All In Biotech

Drug Trial Radar · NCT07652697

ABX-002 Bioequivalence and Effect of Food Study in Healthy Adult Participants

A Phase 1, Open-Label, Randomized, Single Dose Three-Way Crossover Study to Evaluate the Bioequivalence of, and the Effect of Food on, ABX-002 in Healthy Adult Participants

Last checked: Nov 19, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

18

Actual

Start

Jan 2, 2025

Primary completion

Feb 17, 2025

Study completion Feb 17, 2025

Sponsor

Lead sponsor
Autobahn Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this study is to assess the bioequivalence (BE) between the liquid formulation and the new solid formulation of ABX-002 under fasting conditions and to evaluate the effect of food on the pharmacokinetics (PK) of the new solid formulation of ABX-002.This study design is consistent with FDA guidelines for the assessment of BE. This was an open label, randomized, single dose, three-way crossover BE and food-effect study. Therefore, the total number of participants in this study was 18.

Conditions

  • Healthy

Interventions

  • ABX-002Drug

    ABX-002 was supplied as a solution and solid dose form.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulation in healthy adult participants.Time frame: 8 weeks
  2. Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulationTime frame: 8 weeks
  3. Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulationTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Celerion

    Lincoln, Nebraska

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.